These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1155469)

  • 21. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
    Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
    Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
    Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
    Tian LL; Tang X; He HB; Wang J
    Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E.
    Lu Y; Wang Y; Tang X
    Int J Pharm; 2008 Jan; 346(1-2):47-56. PubMed ID: 17640833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics.
    Zhang HY; Tang X; Li HY; Liu XL
    Int J Pharm; 2008 Feb; 348(1-2):70-9. PubMed ID: 17719191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Etomidate using a new solubilizer. Experimental clinical studies on venous tolerance and bioavailability].
    Doenicke A; Kugler A; Vollmann N; Suttmann H; Taeger K
    Anaesthesist; 1990 Oct; 39(10):475-80. PubMed ID: 2278365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of prospective plant oil derived micro-emulsion vehicles for drug delivery.
    Gupta S; Sanyal SK; Datta S; Moulik SP
    Indian J Biochem Biophys; 2006 Aug; 43(4):254-7. PubMed ID: 17133772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of phospholipids on maintenance of the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in aqueous suspension.
    Maker HS; Syed HH; Lehrer GM
    J Natl Cancer Inst; 1978 May; 60(5):1055-7. PubMed ID: 642027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic antileukemic activity of combinations of two nitrosoureas.
    Wheeler GP; Schabel FM; Trader MW
    Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of hexamethylmelamine administered via the Ip route in an oil emulsion vehicle.
    Wickes AD; Howell SB
    Cancer Treat Rep; 1985 Jun; 69(6):657-62. PubMed ID: 3926309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup.
    Carmo-Pereira J; Costa FO; Pimentel P; Henriques E
    Cancer Treat Rep; 1980 Jan; 64(1):143-5. PubMed ID: 7379048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of various nutrient ratios on the emulsion stability of total nutrient admixtures.
    Parry VA; Harrie KR; McIntosh-Lowe NL
    Am J Hosp Pharm; 1986 Dec; 43(12):3017-22. PubMed ID: 3101495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of magnetic emulsion as a novel drug carrier for chemotherapeutic agents.
    Akimoto M; Morimoto Y
    Biomaterials; 1983 Jan; 4(1):49-51. PubMed ID: 6838956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters.
    Bittner B; Mountfield RJ
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):59-71. PubMed ID: 11865674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary diffusion characteristics following administration of a parenteral fat emulsion.
    Moylan JA; Wilmore DW; Spitzer KW; Pruitt BA
    Surg Forum; 1972; 23(0):218-20. PubMed ID: 4671081
    [No Abstract]   [Full Text] [Related]  

  • 37. STUDIES ON A TRANSPARENT AND CONCENTRATED FAT EMULSION FOR INTRAVENOUS USE.
    Mcquarrie EB; Andersen HP
    Am J Clin Nutr; 1965 Jan; 16():23-8. PubMed ID: 14262117
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous fat emulsions; preparation of emulsions and disappearance of intravenously injected fat from the circulation in children.
    KAUSTE O
    Ann Paediatr Fenn; 1958; 4(Supp 10):1-78. PubMed ID: 13595393
    [No Abstract]   [Full Text] [Related]  

  • 39. Side-effect evaluation of a new diazepam formulation: venous sequela reduction following intravenous (i.v.) injection of a diazepam emulsion in rabbits.
    Levy MY; Langerman L; Gottschalk-Sabag S; Benita S
    Pharm Res; 1989 Jun; 6(6):510-6. PubMed ID: 2762228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravenous nutrition with fat emulsions in gynecology and obstetrics].
    HELLER L
    Geburtshilfe Frauenheilkd; 1962 Oct; 22():1049-51. PubMed ID: 13953591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.